img

Mercato degli anticorpi monoclonali biosimilari Mabs per tipo di prodotto (biosimilari di Rituximab, biosimilari di Infliximab, biosimilari di Trastuzumab, biosimilari di Adalimumab, biosimilari di Bevacizumab), applicazione (oncologia, malattie autoimmuni, malattie infettive), utente finale (ospedali, cliniche, istituti di ricerca) e regione per il 2024-2031

Published on: 2024-10-01 | No of Pages : 220 | Industry : latest trending Report

Publisher : MIR | Format : PDF&Excel

Select User License

$2890 Single Licence
$4335 Enterprise Licence
$5780 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email